Virtus Advisers LLC Purchases Shares of 1,017 Chemed Corporation $CHE

Virtus Advisers LLC purchased a new stake in Chemed Corporation (NYSE:CHE) during the second quarter, Holdings Channel reports. The fund purchased 1,017 shares of the company’s stock, valued at approximately $474,000.

Several other large investors have also recently made changes to their positions in the stock. Monetary Solutions Ltd purchased a new position in shares of Chemed during the 4th quarter worth approximately $25,000. Los Angeles Capital Management LLC purchased a new stake in Chemed in the fourth quarter valued at approximately $26,000. BOK Financial Private Wealth Inc. purchased a new stake in Chemed in the fourth quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Chemed during the second quarter worth $34,000. Finally, Versant Capital Management Inc lifted its stake in Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after purchasing an additional 75 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CHE has been the subject of a number of research reports. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Bank of America restated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Royal Bank Of Canada boosted their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Finally, Oppenheimer increased their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $530.75.

Insider Buying and Selling at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the transaction, the chief executive officer owned 70,418 shares of the company’s stock, valued at approximately $37,991,215.18. The trade was a 2.76% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 3,537 shares of company stock valued at $1,782,654. Insiders own 3.33% of the company’s stock.

Chemed Stock Performance

Shares of CHE opened at $534.93 on Friday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $557.00. The stock has a market capitalization of $6.99 billion, a PE ratio of 26.87, a PEG ratio of 2.03 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The stock has a 50-day simple moving average of $496.79 and a 200-day simple moving average of $445.76.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The firm had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, analysts predict that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be given a $0.70 dividend. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is currently 14.06%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.